68Ga-NI-FAPI PET/CT: First-in-human Study

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2025

Study Completion Date

December 31, 2025

Conditions

Malignant Neoplasm

Interventions

DRUG

68Ga-NI-FAPI

Intravenous injection of one dosage of 111-148 MBq (3-4 mCi) 68Ga-NI-FAPI.

Trial Locations (1)

RECRUITING

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou

All Listed Sponsors

lead

First Affiliated Hospital of Fujian Medical University

OTHER